Compounds > rilopirox
Page last updated: 2024-08-25

rilopirox and AIDS-Related Opportunistic Infections

rilopirox has been researched along with AIDS-Related Opportunistic Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haustein, UF; Nenoff, P; Oswald, U; Pfeil, B; Taneva, E1
Haustein, UF; Nenoff, P; Reinl, P1

Reviews

1 review(s) available for rilopirox and AIDS-Related Opportunistic Infections

ArticleYear
[The yeast fungus Malassezia: pathogen, pathogenesis and therapy].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:1

    Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Child; Dermatitis, Atopic; Dermatitis, Seborrheic; Dermatomycoses; Diagnosis, Differential; Female; Folliculitis; Humans; Ketoconazole; Malassezia; Male; Naphthalenes; Pyridones; Scalp Dermatoses; Terbinafine; Tinea Versicolor

2001

Other Studies

1 other study(ies) available for rilopirox and AIDS-Related Opportunistic Infections

ArticleYear
In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection.
    Mycoses, 1999, Volume: 42, Issue:1-2

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Pyridones

1999